CPT code 86408: COVID-19 antibody, neutralizing antibody screen2026 Medicare lab fee · Clinical Laboratory Fee Schedule

This screening test detects SARS-CoV-2 neutralizing antibodies and is reported for screening rather than neutralizing-antibody titer or general quantitative antibody measurement.

CMS CLFS 2026 Q4Effective Oct 1, 2026Same amount nationwide

Medicare pays $42.13 for 86408 under the 2026 Clinical Laboratory Fee Schedule: one national amount, the same in every state and setting.

Medicare lab fee · CLFS 2026 Q4

National CLFS amount

$42.13

In effect since Jan 1, 2026. The same amount in every state, payment locality and setting.

Geographic adjustment
None
Office vs facility
Same
Since 2023
Unchanged
CMS updates
Quarterly

Medicare pays the lesser of the lab’s charge and this amount. Patients usually owe no Part B deductible or coinsurance for covered clinical lab tests.

On this page 8 sections
  1. Medicare lab fee
  2. What 86408 covers
  3. How it’s paid
  4. Amount history
  5. Similar tests
  6. Related codes
  7. Billing questions
  8. Sources

What 86408 covers

86408 identifies a laboratory screen for SARS-CoV-2 neutralizing antibodies. Report it when the service screens for these antibodies rather than measuring and reporting a neutralizing-antibody titer. Code 86409 represents the corresponding titer service, while 86413 represents quantitative SARS-CoV-2 antibody testing; these distinctions separate a neutralizing screen from titer or quantitative antibody reporting.

Medicare pays 86408 only through the Clinical Laboratory Fee Schedule (CLFS); it is excluded from physician fee schedule payment. The 2026 national CLFS amount is $42.13, applying in every state and locality with no geographic or office-versus-facility adjustment. The national amount was also $42.13 in 2023, 2024, and 2025. Report 86408 for screening; use 86409 when a neutralizing-antibody titer is measured and reported.

This summary was written with AI assistance from CMS Clinical Laboratory Fee Schedule data. Amounts on this page come directly from CMS files.

How Medicare pays 86408

Clinical lab tests aren’t priced like physician services. They’re paid from their own fee schedule, with its own rules. See the whole lab fee schedule.

One national amount

CMS sets a single Clinical Laboratory Fee Schedule amount for 86408. There’s no geographic (GPCI) adjustment, so it pays the same in every state and payment locality.

No office or facility rate

Lab tests aren’t built from relative value units, so there’s no office and facility split: the place of service doesn’t change the CLFS amount.

Updated every quarter

CMS republishes the CLFS each quarter. New tests, often proprietary laboratory analyses (PLA codes), join during the year; existing amounts are updated each January.

Excluded from the physician fee schedule

The physician fee schedule lists 86408 with status X (excluded by statute), so the test itself is paid only from the CLFS.

86408 on the lab fee schedule since 2020

86408 · CLFS 2026 Q4 (current)

$42.13

Unchanged since Jan 1, 2023

Amount in each year’s latest CLFS release · bars start at $0

Every change on file

  1. Jan 1, 2023 · CLFS 2023 Q1MAC-priced → $42.13

25 quarterly CLFS releases on file, first CLFS 2020 Q4. A code missing from a quarter wasn’t on that release.

86408 compared with similar tests

86409Neutralizing antibodySARS-CoV-2 titer$79.61
Choose 86408 for neutralizing-antibody screening and 86409 when a neutralizing-antibody titer is measured and reported.
86413COVID-19 antibodyQuantitative measurement$51.43
86413 represents quantitative SARS-CoV-2 antibody testing; 86408 is specifically a screen for neutralizing antibodies.
86769COVID-19 antibodyMultiple-step method$42.13
86769 describes SARS-CoV-2 antibody testing by a multiple-step method, rather than a neutralizing-antibody screen.
86328COVID-19 antibodySingle-step immunoassay$45.28
86328 describes SARS-CoV-2 antibody testing by a single-step method; 86408 identifies neutralizing-antibody screening.

86408 billing questions

How does 86408 differ from 86409?

86408 is for screening for SARS-CoV-2 neutralizing antibodies. Use 86409 when the service measures and reports a neutralizing-antibody titer.

Is 86408 the code for any SARS-CoV-2 antibody test?

No. It identifies a screen for neutralizing antibodies; 86413 represents quantitative SARS-CoV-2 antibody testing.

How does 86408 differ from 86328 and 86769?

86408 is specific to neutralizing-antibody screening. 86328 describes a single-step antibody method, while 86769 describes a multiple-step method.

Does Medicare pay 86408 under the physician fee schedule?

No. Medicare pays 86408 through the CLFS, and the same national amount applies across localities and settings.

Does 86408 include a separately payable physician interpretation?

86408 is paid only through the CLFS and is excluded from physician fee schedule payment.

Where this amount comes from

FeeBase reads lab amounts directly from the CMS Clinical Laboratory Fee Schedule file for the quarter: one row per code, with its payment indicator and national amount. Contractor-priced tests are labeled, never given a made-up amount. Amounts are Medicare payment limits, not a patient’s bill or a commercial rate.

CMS CLFS 2026 Q4 · effective Oct 1, 2026 through the day before Jan 1, 2027

Show the CMS file line behind this amount
CLFS row for 86408PUF_CLFS_CY2026_Q4V1.csv, line 1,721 (CLFS 2026 Q4)

Open CMS sourceHow we source rates

Did this answer your question about what Medicare pays for 86408?

Tell us what you were actually trying to work out. We’ll answer you directly, or build the page that does.

Fee sheets · Coming soon

Put 86408 and the rest of your codes on one sheet

Your codes at your locality, with payer contracts beside Medicare.

Join the waitlist